Literature DB >> 17240285

Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study.

Lara J Wolfson1, Peter M Strebel, Marta Gacic-Dobo, Edward J Hoekstra, Jeffrey W McFarland, Bradley S Hersh.   

Abstract

BACKGROUND: In 2002, the UN General Assembly Special Session on Children adopted a goal to reduce deaths owing to measles by half by the end of 2005, compared with 1999 estimates. We describe efforts and progress made towards this goal.
METHODS: We assessed trends in immunisation against measles on the basis of national implementation of the WHO/UNICEF comprehensive strategy for measles mortality reduction, and the provision of a second opportunity for measles immunisation. We used a natural history model to evaluate trends in mortality due to measles.
RESULTS: Between 1999 and 2005, according to our model mortality owing to measles was reduced by 60%, from an estimated 873,000 deaths (uncertainty bounds 634,000-1,140,000) in 1999 to 345,000 deaths (247,000-458,000) in 2005. The largest percentage reduction in estimated measles mortality during this period was in the western Pacific region (81%), followed by Africa (75%) and the eastern Mediterranean region (62%). Africa achieved the largest total reduction, contributing 72% of the global reduction in measles mortality. Nearly 7.5 million deaths from measles were prevented through immunisation between 1999 and 2005, with supplemental immunisation activities and improved routine immunisation accounting for 2.3 million of these prevented deaths.
INTERPRETATION: The achievement of the 2005 global measles mortality reduction goal is evidence of what can be accomplished for child survival in countries with high childhood mortality when safe, cost-effective, and affordable interventions are backed by country-level political commitment and an effective international partnership.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240285     DOI: 10.1016/S0140-6736(07)60107-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

1.  The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion.

Authors:  Mark A Wurth; Rachel M Schowalter; Everett Clinton Smith; Carole L Moncman; Rebecca Ellis Dutch; Richard O McCann
Journal:  Virology       Date:  2010-08-15       Impact factor: 3.616

2.  Use and abuse of rapid monitoring to assess coverage during mass vaccination campaigns.

Authors:  Elizabeth T Luman; K Lisa Cairns; Robert Perry; Vance Dietz; David Gittelman
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

3.  Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge.

Authors:  Jin K Lee; Andrew Prussia; James P Snyder; Richard K Plemper
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 4.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

5.  Decide monitoring strategies before setting targets.

Authors:  Kenji Shibuya
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

6.  A global action plan for the prevention and control of pneumonia.

Authors:  Brian Greenwood
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

7.  Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review.

Authors:  Hitoshi Murakami; Nguyen Van Cuong; Hong Van Tuan; Katsuyuki Tsukamoto; Do Si Hien
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

8.  Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children.

Authors:  Hamidah Hussain; Dure Samin Akram; Subhash Chandir; Aamir J Khan; Ashraf Memon; Neal A Halsey
Journal:  Hum Vaccin Immunother       Date:  2013-08-08       Impact factor: 3.452

9.  Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.

Authors:  Laura K White; Jeong-Joong Yoon; Jin K Lee; Aiming Sun; Yuhong Du; Haian Fu; James P Snyder; Richard K Plemper
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

10.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.